CG Oncology, Inc. (CGON)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Backbone Bladder-sparing Therapeutic	1.14M	Log In	Log In	Log In
Backbone Bladder-sparing Therapeutic Growth	458.33%	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States	1.14M	Log In	Log In	Log In
United States Growth	458.33%	Log In	Log In	Log In